1888PressRelease.com

Cd-bioparticles.net - Cd Bioparticles Company News Section

Cd Bioparticles Press Release -

Cd-bioparticles.net

CD Bioparticles Announces Offering of Polylactides for Researchers
CD Bioparticles introduces a series of polylactides to support drug delivery research.
December 24, 2021

CD Bioparticles Introduces Customizable MOFs Linkers for Research Use
CD Bioparticles introduces a series of customizable MOFs linkers that can be used as monomers to synthesize MOF materials.
December 02, 2021

CD Bioparticles Announces Spherical Titania Nanoparticles
CD Bioparticles now launches a series of highly-monodisperse spherical titania nanoparticles (Titania Aqueous Dispersion and Titania Ethanol Dispersion).
December 01, 2021

CD Bioparticles Introduces Customizable MOFs Linkers for Research Use
CD Bioparticles introduces a series of customizable MOFs linkers that can be used as monomers to synthesize MOF materials.
November 27, 2021

CD Bioparticles Introduces Organelle & Cell & Tissue Targeting Liposomes Formulation and Development Service
CD Bioparticles introduces organelle & cell & tissue targeting liposomes formulation and development service for drug delivery research.
October 23, 2021

CD Bioparticles Introduces Upconverting Nanoparticle Conjugation Services
CD Bioparticles launches custom upconverting nanoparticles conjugation service using various types of upconverting nanoparticles to conjugate with antibodies.
October 19, 2021

CD Bioparticles Launches PROTAC Linkers for Drug Delivery
CD Bioparticles introduces a series of PROTAC Linkers with various molecular weight and functional groups.
September 15, 2021

CD Bioparticles Launches Cleavable Linkers to Accelerate Customer Research
CD Bioparticles now introduces a series of cleavable linkers to accelerate researchers’ studies.
August 18, 2021

CD Bioparticles Announces Sugar PEGs to Support Research in Drug Delivery
CD Bioparticles introduces the launch of sugar PEGs for potential applications such as uses for biomaterials.
July 20, 2021

CD Bioparticles Continues To Expand Its Metal-organic Frameworks Portfolio With the Launch of Zinc-Based MOFs
CD Bioparticles expands its Metal Organic Frameworks (MOFs) materials portfolio with the launch of Zinc-based MOFs (Fe-MOF) to support drug delivery studies for the research communities.
June 23, 2021

CD Bioparticles Announces Iron-based MOFs (Fe-MOF) to Support Research
CD Bioparticles announces the launch of Iron-based MOFs (Fe-MOF) to support drug delivery research.
May 22, 2021

CD Bioparticles Introduces Lipid Nanoparticle Formulation and Development for mRNA Vaccine Delivery
CD Bioparticles now introduces lipid nanoparticle formulation and development for mRNA vaccine delivery services to research communities.
April 21, 2021

CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers
CD Bioparticles recently introduces a series of dendrimers for research use.
March 13, 2021

CD Bioparticles Launches Chitosans for Research Use
CD Bioparticles launches chitosans for global research communities to support drug delivery studies.
March 04, 2021

CD Bioparticles Releases New Block Copolymer Micelles for Drug Delivery Research
CD Bioparticles launches a series of block copolymer micelles for global researchers.
January 22, 2021

CD Bioparticles Introduces Innovative Fluorescent Polymers to Support Research
CD Bioparticles introduces a series of fluorescent polymers for potential applications.
December 10, 2020

CD Bioparticles Launches Various Metal-organic Frameworks Materials for Research Applications
CD Bioparticles now introduces customized Metal Organic Frameworks (MOFs) materials with various material formats and chemical composition.
November 07, 2020

CD Bioparticles Announces Carbon-based Nanocages Production Services for Researchers
CD Bioparticles introduces carbon-based nanocages production services to global researchers for R&D and commercialization in a variety of applications.
March 25, 2020